ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.62
+0.12 (0.89%)
At close: Aug 10, 2026, 4:00 PM EDT
13.65
+0.03 (0.22%)
After-hours: Aug 10, 2026, 4:24 PM EDT

ORIC Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-156.14-143-142.9-110.78-91.77-78.87
Net Income
-140.35-129.47-127.85-100.7-89.12-78.72
Earnings Per Share
-1.35-1.47-1.83-1.96-2.25-2.07
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
264.76281.49255.96208.19206.27236.98
Net Cash Growth
-6.28%9.97%22.95%0.93%-12.96%-19.29%
Cash & Investments
264.76281.49255.96208.19206.27236.98
Net Cash Per Share
2.553.213.674.055.206.24

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-111.64-110.97-112.66-85.69-75.14-59.54
Capital Expenditures
-0.62-0.71-1.19-0.85-2.08-0.94
Free Cash Flow
-112.26-111.68-113.85-86.54-77.22-60.48
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.